1427 related articles for article (PubMed ID: 16898486)
1. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
2. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
Gellermann J; Ehrich JH; Querfeld U
Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
[TBL] [Abstract][Full Text] [Related]
3. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.
Ulinski T; Dubourg L; Saïd MH; Parchoux B; Ranchin B; Cochat P
Pediatr Nephrol; 2005 Apr; 20(4):482-5. PubMed ID: 15719253
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
Fujinaga S; Ohtomo Y; Hirano D; Nishizaki N; Someya T; Ohtsuka Y; Kaneko K; Shimizu T
Clin Nephrol; 2009 Oct; 72(4):268-73. PubMed ID: 19825332
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
Mendizábal S; Zamora I; Berbel O; Sanahuja MJ; Fuentes J; Simon J
Pediatr Nephrol; 2005 Jul; 20(7):914-9. PubMed ID: 15891923
[TBL] [Abstract][Full Text] [Related]
6. A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome.
Fujinaga S; Ohtomo Y; Umino D; Takemoto M; Shimizu T; Yamashiro Y; Kaneko K
Pediatr Nephrol; 2007 Jan; 22(1):71-6. PubMed ID: 17086405
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab.
Fujinaga S; Someya T; Watanabe T; Ito A; Ohtomo Y; Shimizu T; Kaneko K
Eur J Pediatr; 2013 Apr; 172(4):513-8. PubMed ID: 23271494
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Bagga A; Hari P; Moudgil A; Jordan SC
Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions.
Moudgil A; Bagga A; Jordan SC
Pediatr Nephrol; 2005 Oct; 20(10):1376-81. PubMed ID: 15977023
[TBL] [Abstract][Full Text] [Related]
11. New treatment strategies in idiopathic nephrotic syndrome.
Ulinski T; Aoun B
Minerva Pediatr; 2012 Apr; 64(2):135-43. PubMed ID: 22495188
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
Fujinaga S; Hirano D; Nishino T; Umeda C; Watanabe Y; Nakagawa M
Pediatr Nephrol; 2019 Nov; 34(11):2417-2421. PubMed ID: 31435725
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil for treatment of idiopathic nephrotic syndrome in children.
Nickavar A; Safarzadeh AE; Sotoudeh K; Otukesh H; Hooman N
Iran J Kidney Dis; 2012 Sep; 6(5):346-9. PubMed ID: 22976259
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
Wang J; Mao J; Chen J; Fu H; Shen H; Zhu X; Liu A; Shu Q; Du L
Nephrology (Carlton); 2016 Jan; 21(1):21-7. PubMed ID: 26697959
[TBL] [Abstract][Full Text] [Related]
16. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
Hibino S; Uemura O; Nagai T; Yamakawa S; Iwata N; Ito H; Nakano M; Tanaka K
Pediatr Int; 2015; 57(1):85-91. PubMed ID: 25225083
[TBL] [Abstract][Full Text] [Related]
17. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
Li X; Tian J; Wu J; He Q; Li H; Han F; Li Q; Chen Y; Ni Q; Chen J
Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
[TBL] [Abstract][Full Text] [Related]
18. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
[TBL] [Abstract][Full Text] [Related]
19. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Larkins NG; Liu ID; Willis NS; Craig JC; Hodson EM
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002290. PubMed ID: 32297308
[TBL] [Abstract][Full Text] [Related]
20. Fifteen-year remission of a steroid-resistant nephrotic syndrome sustained by cyclosporine A.
Drube J; Geerlings C; Taylor R; Mengel M; Ehrich JH
Pediatr Nephrol; 2007 Apr; 22(4):600-2. PubMed ID: 17235550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
